Mucinous Neoplasm

histology

Identifier: CI-CAN-00001237
Entity page: /cancer/mucinous-neoplasm ↗
Edges: 234

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Mucinous Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 56show all (up to 200)
→ investigated in trials for	Paclitaxelsmall molecule 26 trials (6 active) · roll-up of the cancer and its descendants	—	—	Mucinous Neoplasm	26	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule

Mucinous Neoplasm studied in …STUDIED_INderived10 of 178show all (up to 200)
→ studied in	NCT05112601Phase 2 · recruiting Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma · condition mapped ONTOLOGY_EXACT · 178 trials mapped (59 active)	—	—	Endometrial Mucinous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06084780Phase 2 · not yet recruiting Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE) · condition mapped ONTOLOGY_EXACT · 178 trials mapped (59 active)	—	—	Pseudomyxoma Peritonei	1	Observed	clinicaltrials	graph →
→ studied in	NCT04291651recruiting UCSF PANC Cyst Registry · condition mapped ONTOLOGY_EXACT · 178 trials mapped (59 active)	—	—	Pancreatic Intraductal Papillary Mucinous Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT02101775Phase 2 · active not recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 178 trials mapped (59 active)	—	—	Ovarian Mucinous Cystadenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04207944Phase 2 · active not recruiting The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) · condition mapped ALIAS · 178 trials mapped (59 active)	—	—	Pancreatic Intraductal Papillary Mucinous Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT01617382recruiting Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed · condition mapped ONTOLOGY_EXACT · 178 trials mapped (59 active)	—	—	Pseudomyxoma Peritonei	1	Observed	clinicaltrials	graph →
→ studied in	NCT01081262Phase 3 · active not recruiting Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 178 trials mapped (59 active)	—	—	Borderline Ovarian Mucinous Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT02142803Phase 1 · active not recruiting TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 178 trials mapped (59 active)	—	—	Ovarian Mucinous Cystadenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07753824Phase 2 · not yet recruiting A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA) · condition mapped PROBABILISTIC · 178 trials mapped (59 active)	—	—	Mucinous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02068794Phase 1/Phase 2 · active not recruiting MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 178 trials mapped (59 active)	—	—	Fallopian Tube Mucinous Adenocarcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains